The BRICS dialysis concentrates and solutions market size is expected to reach US$ 797.6 million by 2031 from US$ 532.3 million in 2024. The market is estimated to record a CAGR of 5.9% from 2025 to 2031.
Executive Summary and BRICS Dialysis Concentrates and Solutions Market Analysis:
The dialysis concentrates and solutions market across BRICS is witnessing significant growth, majorly fueled by rising dialysis volume, increasing customization of dialysis compositions, and strong government support in emerging economies. BRICS represents a cluster of high-potential markets, each with distinct dynamics and growth trajectories. Chronic Kidney Disease (CKD) continues to impose a significant global healthcare burden, driving demand for dialysis services. Governments and private players are increasing their investments to expand healthcare infrastructure, further accelerating market growth. China and India lead the surge, propelled by large population bases and improving access to care. The market in Brazil, though more mature, benefits from a sizable patient base and steady demand. On the flip side, Russia and South Africa face structural challenges, including limited infrastructure and systemic inefficiencies, which constrain growth. Across all BRICS nations, in-center hemodialysis remains the dominant treatment modality, underpinning strong demand for concentrates and solutions. Future market expansion will hinge on ongoing healthcare reforms and the ability of these countries to scale dialysis services to meet rising demand.
BRICS Dialysis Concentrates and Solutions Market Segmentation Analysis:
Key segments that contributed to the derivation of the dialysis concentrates and solutions market analysis are product, application, and end user.
- By product, the dialysis concentrates and solutions market is segmented into acid concentrates, bicarbonate concentrates, powdered concentrates, dialysate, and electrolyte solutions. Acid concentrates dominated the market in 2024, driven by their critical role and high-volume utilization as a core component in hemodialysis, which is the predominant treatment modality across BRICS countries.
- In terms of application, the market is segmented into hemodialysis and peritoneal dialysis. Hemodialysis accounted for a larger share in 2024, driven by its long-standing position as the primary treatment for end-stage renal disease (ESRD). This dominance is supported by a substantial patient base and well-established, publicly funded clinical infrastructure across the region.
- By end user, the market is segmented into in-center dialysis settings and home care settings. In-center dialysis dominated the market in 2024, driven by the high prevalence of advanced-stage patients with comorbidities requiring continuous medical supervision. Limited infrastructure and inadequate patient training for home-based care in many parts of the region further reinforce this segment’s leadership.
BRICS Dialysis Concentrates and Solutions Market Outlook
Market prospects are set for dynamic evolution, driven by economic growth and shifts in healthcare delivery. Advancing healthcare infrastructure and rising expenditure across BRICS nations are reshaping the landscape. Governments and private players are investing heavily in dialysis facilities to meet growing patient demand. A notable trend is the transition toward home-based therapies, including peritoneal dialysis, offering greater convenience and flexibility. This shift opens new opportunities for specialized concentrates and solutions tailored for home use. Global leaders such as Fresenius Medical Care, Baxter International, and B. Braun maintain strong positions, while local manufacturers are gaining traction and expanding market share. Competition centers on technology innovation, R&D, and strategic partnerships to enhance product efficacy and accessibility. Despite significant opportunities, challenges persist—high treatment costs and limited reimbursement frameworks restrict access, particularly in rural and underserved regions. Nevertheless, BRICS is poised to remain a critical growth engine for the global dialysis concentrates and solutions market in the coming years.
BRICS Dialysis Concentrates and Solutions Market Country Insights
The BRICS dialysis concentrates and solutions market includes Brazil, Russia, India, China, South Africa, Egypt, Indonesia, the UAE, and Saudi Arabia. The BRICS dialysis concentrates and solutions market exhibits significant country-level diversity. China leads the region, driven by a large aging population, rapid urbanization, and high prevalence of hypertension and diabetes. Government initiatives to expand dialysis infrastructure, particularly in semi-rural areas, and growing acceptance of home dialysis are accelerating growth. India is witnessing rising dialysis demand due to lifestyle-related illnesses. Private providers dominate service delivery, while government programs supporting dialysis care and mobile access are improving reach in underserved regions. Brazil benefits from its well-established public healthcare system (SUS), which offers free dialysis treatment, creating a substantial patient base. Increasing private investment is fueling interest in home-based dialysis solutions. A growing geriatric population and adoption of modern dialysis technologies in hospitals support the market growth in Russia. However, high treatment costs and limited remote-care infrastructure remain key barriers. South Africa faces a heavy burden of hypertension and diabetes, yet inadequate public healthcare infrastructure constrains dialysis access, highlighting a critical need for capacity expansion.
BRICS Dialysis Concentrates and Solutions Market Company Profiles
Fresenius Medical Care AG & Co KGaA; Baxter International Inc.; B. Braun SE; Nipro Corp; Medtronic Plc; Nikkiso Co., Ltd; Teleflex Inc; Asahi Kasei Medical Co., Ltd.; Terumo Corp; and DaVita Inc. are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.
BRICS Dialysis Concentrates and Solutions Market Research Methodology:
The following methodology has been followed for the collection and analysis of data presented in this report:
-
Secondary Research
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
- Company websites, annual reports, financial statements, broker analyses, and investor presentations
- Industry trade journals and other relevant publications
- Government documents, statistical databases, and market reports
- News articles, press releases, and webcasts specific to companies operating in the market
Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.
-
Primary Research
Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:
- Refine findings from secondary research
- Enhance the expertise and market understanding of the analysis team
- Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects
Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:
- Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
- External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Key Sources Referred:
- World Health Organization (WHO)
- United States Renal Data System (USRDS)
- The World Bank Group
- Worldometer
- The Lancet
- International Trade Administration
BRICS Dialysis Concentrates and Solutions Market Strategic Insights
BRICS Dialysis Concentrates and SolutionsMarket Report Highlights
| Report Attribute | Details |
| Market size in 2024 | US$ 532.3 Million |
| Market Size by 2031 | US$ 797.6 Million |
| CAGR (2025 - 2031) | 5.9% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Product
|
|
Regions and Countries Covered
|
|
| BRICS | Russia, Brazil, South Africa, India, China, Egypt, Indonesia, United Arab Emirates, Saudi Arabia |
| Market leaders and key company profiles |
|
BRICS Dialysis Concentrates and Solutions Market Country and Regional Insights
